Literature DB >> 17230603

Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats.

Osamah Hussein1, Masha Grosovski, Etti Lasri, Sergio Svalb, Uzi Ravid, Nimer Assy.   

Abstract

AIM: To evaluate the effects of different types of dietary fats on the hepatic lipid content and oxidative stress parameters in rat liver with experimental non-alcoholic fatty liver disease (NAFLD).
METHODS: A total of 32 Sprague-Dawley rats were randomly divided into five groups. The rats in the control group (n = 8) were on chow diet (Group 1), rats (n = 6) on methionine choline-deficient diet (MCDD) (Group 2), rats (n = 6) on MCDD enriched with olive oil (Group 3), rats (n = 6) on MCDD with fish oil (Group 4) and rats (n = 6) on MCDD with butter fat (Group 5). After 2 mo, blood and liver sections were examined for lipids composition and oxidative stress parameters.
RESULTS: The liver weight/rat weight ratio increased in all treatment groups as compared with the control group. Severe fatty liver was seen in MCDD + fish oil and in MCDD + butter fat groups, but not in MCDD and MCDD + olive oil groups. The increase in hepatic triglycerides (TG) levels was blunted by 30% in MCDD + olive oil group (0.59 +/- 0.09) compared with MCDD group (0.85 +/- 0.04, P < 0.004), by 37% compared with MCDD + fish oil group (0.95 +/- 0.07, P < 0.001), and by 33% compared with MCDD + butter group (0.09 +/- 0.1, P < 0.01). The increase in serum TG was lowered by 10% in MCDD + olive oil group (0.9 +/- 0.07) compared with MCDD group (1.05 +/- 0.06). Hepatic cholesterol increased by 15-fold in MCDD group [(0.08 +/- 0.02, this increment was blunted by 21% in MCDD + fish oil group (0.09 +/- 0.02)]. In comparison with the control group, ratio of long-chain polyunsaturated fatty acids omega-6/omega-3 increased in MCDD + olive oil, MCDD + fish oil and MCDD + butter fat groups by 345-, 30- and 397-fold, respectively. In comparison to MCDD group (1.58 +/- 0.08), hepatic MDA contents in MCDD + olive oil (3.3 +/- 0.6), MCDD + fish oil (3.0 +/- 0.4), and MCDD + butter group (2.9 +/- 0.36) were increased by 108%, 91% and 87%, respectively (P < 0.004). Hepatic paraoxonase activity decreased significantly in all treatment groups, mostly with MCDD + olive oil group (-68%).
CONCLUSION: Olive oil decreases the accumulation of triglyceride in the liver of rats with NAFLD, but does not provide the greatest antioxidant activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17230603      PMCID: PMC4065889          DOI: 10.3748/wjg.v13.i3.361

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  42 in total

1.  Hepatic paraoxonase activity alterations and free radical production in rats with experimental cirrhosis.

Authors:  N Ferré; J Camps; M Cabré; A Paul; J Joven
Journal:  Metabolism       Date:  2001-09       Impact factor: 8.694

2.  Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage.

Authors:  Natàlia Ferré; Jordi Camps; Eduard Prats; Elisabet Vilella; Antoni Paul; Lídia Figuera; Jorge Joven
Journal:  Clin Chem       Date:  2002-02       Impact factor: 8.327

Review 3.  Mechanisms of hepatotoxicity.

Authors:  Hartmut Jaeschke; Gregory J Gores; Arthur I Cederbaum; Jack A Hinson; Dominique Pessayre; John J Lemasters
Journal:  Toxicol Sci       Date:  2002-02       Impact factor: 4.849

Review 4.  Peroxisome proliferator-activated receptors: from genes to physiology.

Authors:  S A Kliewer; H E Xu; M H Lambert; T M Willson
Journal:  Recent Prog Horm Res       Date:  2001

Review 5.  Fatty acid oxidation and signaling in apoptosis.

Authors:  Dean G Tang; Eunhye La; Julie Kern; James P Kehrer
Journal:  Biol Chem       Date:  2002 Mar-Apr       Impact factor: 3.915

Review 6.  Nonalcoholic steatosis and steatohepatitis. I. Molecular mechanism for polyunsaturated fatty acid regulation of gene transcription.

Authors:  S D Clarke
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-10       Impact factor: 4.052

7.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

Authors:  Kerry L Donnelly; Coleman I Smith; Sarah J Schwarzenberg; Jose Jessurun; Mark D Boldt; Elizabeth J Parks
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

Review 8.  Animal models of steatosis.

Authors:  A Koteish; A M Diehl
Journal:  Semin Liver Dis       Date:  2001       Impact factor: 6.115

9.  Differential oxidation of individual dietary fatty acids in humans.

Authors:  J P DeLany; M M Windhauser; C M Champagne; G A Bray
Journal:  Am J Clin Nutr       Date:  2000-10       Impact factor: 7.045

10.  Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients.

Authors:  M Cassader; R Gambino; G Musso; N Depetris; F Mecca; P Cavallo-Perin; G Pacini; M Rizzetto; G Pagano
Journal:  Lipids       Date:  2001-10       Impact factor: 1.880

View more
  26 in total

1.  High dietary intake of palm oils compromises glucose tolerance whereas high dietary intake of olive oil compromises liver lipid metabolism and integrity.

Authors:  Youzan Ferdinand Djohan; Eric Badia; Beatrice Bonafos; Gilles Fouret; Céline Lauret; Anne-Marie Dupuy; Edith Pinot; Thibault Sutra; Sylvie Gaillet; Karen Lambert; Fabrice Raynaud; Nathalie Gayrard; Bernard Jover; Absalome Aké Monde; Jean Paul Cristol; Charles Coudray; Christine Feillet-Coudray
Journal:  Eur J Nutr       Date:  2018-11-03       Impact factor: 5.614

2.  High-fat and obesogenic diets: current and future strategies to fight obesity and diabetes.

Authors:  João S Teodoro; Ana T Varela; Anabela P Rolo; Carlos M Palmeira
Journal:  Genes Nutr       Date:  2014-05-20       Impact factor: 5.523

3.  Effect of a Low Glycemic Index Mediterranean Diet on Non-Alcoholic Fatty Liver Disease. A Randomized Controlled Clinici Trial.

Authors:  G Misciagna; M Del Pilar Díaz; D V Caramia; C Bonfiglio; I Franco; M R Noviello; M Chiloiro; D I Abbrescia; A Mirizzi; M Tanzi; M G Caruso; M Correale; R Reddavide; R Inguaggiato; A M Cisternino; A R Osella
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

4.  trans-Fatty acids promote proinflammatory signaling and cell death by stimulating the apoptosis signal-regulating kinase 1 (ASK1)-p38 pathway.

Authors:  Yusuke Hirata; Miki Takahashi; Yuki Kudoh; Kuniyuki Kano; Hiroki Kawana; Kumiko Makide; Yasuharu Shinoda; Yasushi Yabuki; Kohji Fukunaga; Junken Aoki; Takuya Noguchi; Atsushi Matsuzawa
Journal:  J Biol Chem       Date:  2017-03-29       Impact factor: 5.157

Review 5.  Modulation of hepatic steatosis by dietary fatty acids.

Authors:  Alessandra Ferramosca; Vincenzo Zara
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

6.  Beneficial effect of a weight-stable, low-fat/low-saturated fat/low-glycaemic index diet to reduce liver fat in older subjects.

Authors:  Kristina M Utzschneider; Jennifer L Bayer-Carter; Matthew D Arbuckle; Jaime M Tidwell; Todd L Richards; Suzanne Craft
Journal:  Br J Nutr       Date:  2012-07-31       Impact factor: 3.718

Review 7.  Nutrigenomics therapy of hepatisis C virus induced-hepatosteatosis.

Authors:  Qing Liu; Stig Bengmark; Shen Qu
Journal:  BMC Gastroenterol       Date:  2010-05-20       Impact factor: 3.067

Review 8.  Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials.

Authors:  Shira Zelber-Sagi; Justyna Godos; Federico Salomone
Journal:  Therap Adv Gastroenterol       Date:  2016-03-17       Impact factor: 4.409

Review 9.  Olive oil consumption and non-alcoholic fatty liver disease.

Authors:  Nimer Assy; Faris Nassar; Gattas Nasser; Maria Grosovski
Journal:  World J Gastroenterol       Date:  2009-04-21       Impact factor: 5.742

10.  Carbon tetrachloride-induced liver disease in rats: the potential effect of supplement oils with vitamins E and C on the nutritional status.

Authors:  Rasha S A Ismail; Ashraf A A El-Megeid; Aly R Abdel-Moemin
Journal:  Ger Med Sci       Date:  2009-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.